MIR News and Press, Mirion Technologies Inc. Class A From 02/14/23

Revenues for the fourth quarter increased 22.6% to $217.9 million, compared to $177.8 million in the same period in 2021. Adjusted revenues increased 20.5% compared to the fourth quarter of 2021. GAAP net loss was $159.7 million in the fourth quarter. Adjusted EBITDA was $56.4 million for...

Mirion Technologies, Inc. (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Citi’s 2023 Global Industrial Tech and Mobility Conference in Miami, FL. The presentation will begin at 1:50 PM ET on Tuesday, Febr...

Mirion Technologies, Inc. (NYSE: MIR) (“Mirion”) (“Company”) announced today that it will release its financial results for the fourth quarter and fiscal year 2022 on Tuesday, February 14, 2023. Following the news release, the Company will host a conference call the sa...

Scripps Health Radiation Therapy Centers Named Patient Safety Center of Excellence by Sun Nuclear PR Newswire Designation Recognizes Partnership for Improved Quality Management and Enhanced Patient Care in Radiation Therapy MELBOURNE, Fla. , Jan. 26, 2023...

HALIFAX, NS / ACCESSWIRE / January 11, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the receipt of the CE mark for its VYRA™ CoV2Flu Antigen Test (VYRA™ CoV2Flu), the fastest combination antigen test available to detect SARS-CoV-2, Flu A and Flu B. The Company received...

Mirion Technologies, Inc. (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at the CJS Securities 23rd Annual New Ideas for the New Year Conference. The presentation will begin at 3:45 PM ET on Wednesday, January 11, ...

HALIFAX, NS / ACCESSWIRE / January 3, 2023 / Today, MedMira Inc. (MedMira) (TSXV:MIR) announces the publication of Point-of-Care Diagnostic for Trichomonas vaginalis, the Most Prevalent, Non-Viral Sexually Transmitted Infection - ( available: https://www.mdpi.com/2076-0817/12/1/77 ), in the ...

Mirion Technologies, Inc. (NYSE: MIR) announced today that it has entered into a definitive agreement to sell the physical medicine assets of Biodex Medical Systems, Inc. (“Biodex”) to Salona Global Medical Device Corporation for $5 million in cash at closing and up to an ...

SAN DIEGO, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Salona Global Medical Device Corporation (“ Salona Global ,” “ SGMD ,” or the “ Company ”) (TSXV:SGMD) has executed a definitive asset purchase agreement (the “ Asset Purchase...

The following slide deck was published by Mirion Technologies, Inc. in conjunction with their 2022 Q3 earnings call. For further details see: Mirion Technologies, Inc. 2022 Q3 - Results - Earnings Call Presentation